Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: Lessons from knockout mice

Current Opinion in Lipidology

Volumn 12, Issue 2, 2001, Pages 175-180

  Peters, Wendy ^a   Charo, Israel F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR 2; CYTOKINE; GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOAM CELL; IN VIVO STUDY; KNOCKOUT MOUSE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CHEMOKINE CCL2; INTERFERON TYPE II; MACROPHAGES; MICE; MICE, KNOCKOUT; MONOCYTES; RECEPTORS, CHEMOKINE;

EID: 0035076642     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200104000-00011     Document Type: Review

References (73)

1. Regulation of the macrophage content of neoplasms by chemoattractants
2. Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice
3. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
4. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE
5. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells
6. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
7. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice
8. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
9. Chemokines
10. Human chemokines: An update
11. The biology of chemokines and their receptors
12. The role of chemokine receptors in primary, effector, and memory immune responses
13. Molecular cloning and functional characterization of human lymphotactin
14. 3C motif
15. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
16. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture
17. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
18. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
19. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family
20. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3
21. 2+ mobilization, and enzyme release
22. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
23. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
24. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor
25. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
26. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells
27. Atherosclerosis: An inflammatory disease
28. Changing concepts of atherogenesis
29. Atherosclerosis: From lesion formation to plaque activation and endothelial dysfunction
30. The role of the monocyte in atherogenesis. I. Transition of bloodborne monocytes into foam cells in fatty lesions
31. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation
32. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
33. Monocyte chemoattractant protein-1 in human atheromatous plaques
34. Local expression of inflammatory cytokines in human atherosclerotic plaques
35. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
36. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
37. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
38. -/- mice reveals a role for chemokines in the initiation of atherosclerosis
39. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
40. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
41. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
42. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet
43. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
44. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
45. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma
46. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
47. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
48. Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the apoE knockout mouse
49. Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tumor necrosis factor-α and interleukin-1β
50. Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia: Differential effects of plasma lipoproteins on monocyte function
51. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor γ
52. Defects in the generation of IFN-γ are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1α-, or CCR2-deficient mice
53. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection
54. A mechanism for the impaired IFN-γ production in C-C chemokine receptor 2 (CCR2) knockout mice: Role of CCR2 in linking the innate and adaptive immune responses
55. Cell-mediated immunity in atherosclerosis
56. Participation of innate and acquired immunity in atherosclerosis
57. CD40 signaling in vascular cells: A key role in atherosclerosis? [Supplement]
58. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice
59. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice
60. -/- mice
61. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
62. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis
63. Immunological response to oxidized LDL. [Supplement]
64. IFN-γ potentiates atherosclerosis in apoE knock-out mice
65. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice
66. H2 polarization by the chemokine monocyte chemoattractant protein-1
67. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production
68. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques
69. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells
70. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis. Using genomic technology to identify a potential novel pathway of vascular inflammation
71. Human vascular smooth muscle cells possess functional CCR5
72. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques
73. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells